lan
Lv4
640 积分
2022-07-26 加入
-
A continuous-time multistate Markov model to describe the occurrence and severity of diarrhea events in metastatic breast cancer patients treated with lumretuzumab in combination with pertuzumab and paclitaxel
20小时前
已完结
-
Population pharmacokinetic/pharmacodynamic modeling of tumor growth kinetics in medullary thyroid cancer patients receiving cabozantinib
20小时前
已完结
-
Recent advances in the trifluoromethylation methodology and new CF3-containing drugs
6天前
已完结
-
Safety, pharmacokinetics and pharmacodynamics of HRS‐7535, a novel oral small molecule glucagon‐like peptide‐1 receptor agonist, in healthy participants: A phase 1, randomized, double‐blind, placebo‐controlled, single‐ and multiple‐ascending dose, and food effect trial
28天前
已完结
-
Plasma and whole blood pharmacokinetics of topiramate: the role of carbonic anhydrase
1个月前
已完结
-
Prediction of human blood‐to‐plasma drug concentration ratio
1个月前
已完结
-
Application of allometric principles for the prediction of pharmacokinetics in human and veterinary drug development
1个月前
已完结
-
Incidence of Anti-Drug Antibodies to Monoclonal Antibodies in Asthma: A Systematic Review and Meta-Analysis
1个月前
已完结
-
Optimizing the safety of antibody–drug conjugates for patients with solid tumours
2个月前
已完结
-
Population Pharmacokinetic Modeling of JNJ-53718678, a Novel Fusion Inhibitor for the Treatment of Respiratory Syncytial Virus: Results from a Phase I, Double-Blind, Randomized, Placebo-Controlled First-in-Human Study in Healthy Adult Subjects
2个月前
已完结